2 ms·
It can’t be done effectively during exponential growth at the current rate: there simply aren’t enough identified recovered patients to supply serum to the curr
by amluto 7y ago
It can’t be done effectively during exponential growth at the current rate: there simply aren’t enough identified recovered patients to supply serum to the currently sick patients. If the exponential rate decreases a bit, maybe.
FWIW, it seems at least plausible to me that a recovered patient who was treated with serum may not generate as many protective antibodies as a naturally recovered patient. For example, Rh antibodies are used during pregnancy specifically to prevent an immune response. I don’t know if this would apply to COVID-19 or if giving serum only after symptoms become severe would prevent this outcome.
- nil-sec 7y agoSee my reply to your original comment. Exponential growth isn’t a valid reason for this to not work. The factor of recovered vs currently Ill patients is constant, exponential growth or not. This factor may be high and I assume this is what you mean but given the (relatively small) percentage of critically ill and the fact that some countries are further along this is not a clear disqualifying argument against serum.